Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS
· Delayed Price · Currency is USD
0.1098
+0.0060 (5.78%)
Mar 31, 2025, 3:26 PM EST
Enzon Pharmaceuticals Company Description
Enzon Pharmaceuticals, Inc., together with its subsidiaries, does not have significant operations.
Previously, it sells its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002.
Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.
Enzon Pharmaceuticals, Inc.
| Country | United States |
| Founded | 1981 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Richard Feinstein |
Contact Details
Address: 20 Commerce Drive Cranford, Delaware 07016 United States | |
| Phone | 732 980 4500 |
| Website | enzon.com |
Stock Details
| Ticker Symbol | ENZN |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US2939041081 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Richard L. Feinstein CPA | Chief Executive Officer, Chief Financial Officer and Secretary |